ATCT-01 PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG)

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Affronti, Mary L., Friedman, Henry S., Desjardins, Annick, Vlahovic, Gordana, Randazzo, Dina M., Herndon, James E., McSherry, Frances, Lipp, Eric S., Mannerico, Alex, Massey, Woody, Miller, Elizabeth, Iden, Deborah, Peters, Katherine B.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638552/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov206.01
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares